FDA Grants Accelerated Approval To Verastem's Combination Drug For Ovarian Cancer

What’s in the new US-UK trade deal? How will Trump’s tariffs impact carmakers? Why was Celsius founder sentenced to prison? What caused Bitcoin to surge past $100,000? How is Meta re-entering the stablecoin market? Why did the Federal Reserve hold interest rates? How did the UK rate cut respond to trade tensions? What’s behind Peloton’s latest revenue forecast rise? Why are companies passing tariffs costs to consumers?

FDA Grants Accelerated Approval To Verastem's Combination Drug For Ovarian Cancer

benzinga.com/general/biotech/25/05/45297255/fda-grants-accelerated-approval-to-verastems-combination-drug-for-ovarian-cancer

The Food and Drug Administration on Thursday granted accelerated approval to Verastem Inc.’s (NASDAQ:VSTM) Avmapki Fakzynja Co-pack, a combination of avutometinib and defactinib for adult patients with KRAS-mutated recurrent low-grade serous ovarian cancer (LGSOC) who have received prior…

This story appeared on benzinga.com, 2025-05-08 18:47:09.